| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development | $1.4M-78.1% | $6.5M-13.3% | $7.4M+43.2% | $5.2M |
| General and administrative | $3.1M-11.5% | $3.5M-53.1% | $7.4M+4.3% | $7.1M |
| Total operating expenses | $4.5M-54.7% | $9.9M-33.2% | $14.9M+20.7% | $12.3M |
| Loss from operations | -$4.5M+54.7% | -$9.9M+33.2% | -$14.9M-20.7% | -$12.3M |
| Interest expense | -$18K-78.5% | -$10K-31.2% | -$8K+83.4% | -$47K |
| Total other expense, net | -$18K-78.5% | -$10K-31.2% | -$8K+81.9% | -$43K |
| NET LOSS | -$4.5M+54.6% | -$9.9M+33.1% | -$14.9M-20.4% | -$12.4M |
| Dividend on preferred shares | -$117K | — | — | — |
| Deemed dividend on warrant modification issued with preferred | -$473K | — | — | — |
| NET LOSS ATTRIBUTED TO COMMON SHARES | -$5.1M+48.7% | -$9.9M | — | — |
| Basic net loss per common share | -$11.32+91.4% | -$132.33-478.1% | -$22.89-16250.0% | -$0.14 |
| Diluted net loss per common share | -$11.32+91.4% | -$132.33-478.1% | -$22.89-16250.0% | -$0.14 |
| Basic weighted average common shares outstanding | 451K+507.8% | 74K-88.6% | 650K-99.3% | 89.1M |
| Diluted weighted average common shares outstanding | 451K+507.8% | 74K-99.9% | 97.5M+9.5% | 89.1M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.